Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update Biotech Investing
Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 Pharmaceutical Investing
Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma Life Science Investing News
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights Life Science Investing News
Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update Pharmaceutical Investing
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder Pharmaceutical Investing
MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program Cannabis Investing News
